Phorbol ester-stimulated phosphorylation of PU.1: Association with leukemic cell growth inhibition

Blood

Volumn 87, Issue 10, 1996, Pages 4316-4324

  Carey, Julie O ^b   Posekany, Karla J ^b   DeVente, James E ^b   Pettit, George R ^b   Ways, D Kirk ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; BRYOSTATIN 1; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE INHIBITOR; TRANSCRIPTION FACTOR;

ARTICLE; BINDING AFFINITY; CELL DIFFERENTIATION; CELL MATURATION; DNA BINDING; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION;

EID: 0029876729     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.10.4316.bloodjournal87104316     Document Type: Article

References (35)

1. Ray D, Culene S, Tavitian A, Moreau-Gachelin F: The human homologue of the putative proto-oncogene Spi-1: Characterization and expression in tumors. Oncogene 5:663, 1990
2. Klemsz M, McKercher S, Celada A, VanBeveren C, Maki R: The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell 61:113, 1990
3. Scott E, Simon M, Anastasi J, Singh H: Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265:1573, 1994
4. Hickstein D, Baker D, Gollahon K, Back A: Identification of the promoter of the myetomonocytic leukocyte integrin CD11b. Proc Natl Acad Sci USA 89:2105, 1992
5. Rosmarin A, Levy R, Tenen D: Cloning and analysis of the CD18 promoter. Blood 79:2598, 1992
6. Bottinger E, Shelley C, Farokhzad O, Arnaout M: The human beta ζ integrin CD18 promoter consists of two inverted ETS cis elements. Mol Cell Biol 14:2604, 1994
7. Pahl H, Scheibe R, Zhang D, Chen H, Galson D, Maki R, Tenen D: The proto-oncogene PU.1 regulates expression of the myeloid-specific CD11b promoter. J Biol Chem 268:5014, 1993
8. Lopez-Cabrera M, Nueda A, Vara A, Garcia-Aguilar J, Tugores A, Lorbi A: Characterization of the p150,95 leukocyte integrin alpha subunit (CD11c) gene promoter. Identification of cis-acting elements. J Biol Chem 268:1187, 1993
9. Zhang D, Hetherington C, Chen H, Tenen D: The macrophage transcription factor PU.1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor. J Biol Chem 14:373, 1994
10. Moulton M, Simple K, Un H, Glass C: Cell-specific expression of the macrophage scavenger receptor gene is dependent on PU.1 and a composite AP-1/ets motif. Mol Cell Biol 14:4408, 1994
11. Ahne B, Stratling W: Characterization of a myeloid-specific enhancer of the chicken lysozyme gene. Major role for an ETS transcription factor-binding site. J Biol Chem 269:17794, 1994
12. Voso M, Burn T, Wulf G, Lim B, Leone G, Tenen D: Inhibition of hematopoiesis by competitive binding of transcription factor PU-1. Proc Natl Acad Sci USA 91:7932, 1994
13. Pongubala J, Nagulapalli S, Klemsz M, McKercher S, Maki R, Atchison M: PU.1 recruits a second nuclear factor to a site important for immunoglobulin Kappa 3′ enhancer activity. Mol Cell Biol 12:368, 1992
14. Pongubala J, Van Beveren C, Nagulapalli S, Klemsz M, McKercher S, Maki R, Atchism M: Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation. Science 259:1622, 1993
15. Hromas R, Orazi A, Neiman R, Maki R, Van Beveran C, Moore J, Klemsz M: Hematopoietic lineage- and state-restricted expression of the ETS oncogene family member PU.1. Blood 82:2998, 1993
16. Sariban E, Mitchell T, Kufe D: Expression of the c-fms proto oncogene during human monocytic differentiation. Nature 316:64, 1985
17. Ways DK, Kiley S, Garris T, Hooker J, deVente J, Posekany K, Parker P, Cook P, Reicher D: Phorbol ester treatment of U937 with altered protein kinase C content and distribution induces cell death rather than differentiation. Cell Growth Diff 6:371, 1995
18. Pettit G, Herald C, Doubek D, Arnold E, Clardy J: Antineoplastic agents 86. Isolation and structure of bryostatin 1. J Am Chem Soc 104:6846, 1982
19. Ways DK, Kukoly C, de Vente J, Hooker JL, Bryant WO, Posekany K, Fletcher DJ, Cook PP, Parker PJ: MCF-7 breast cancer cells transfected with protein kinase C-α exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype. J Clin Invest 95:1906, 1995
20. Ray D, Bosselut R, Ghysdael J, Mattei M, Tavitian A, Moreau-Gachelin F: Characterization of Spi-B, a transcription factor related to the putative oncoprotein Spi-1/PU.1. Mol Cell Biol 12:4297, 1992
21. Delgado M, Hallier M, Menesceur P, Tavitian A, Moreau-Gachelin F: Inhibition of Friend cells proliferation by Spi-1 antisense oligodeoxynucleotides. Oncogene 9:1723, 1994
22. Aihara H, Asaoka Y, Yoshida K, Nishizuka Y: Sustained activation of protein kinase C is essential to HL-60 cell differentiation to macrophage. Proc Natl Acad Sci USA 87:2294, 1990
23. Ways DK, Dodd RC, Earp HS: Dissimilar effects of phorbol ester and diacylglycerol derivative on protein kinase activity and differentiation. Cancer Res 47:3344, 1987
24. David P, Elliott L, Harris W, Hill C, Hurst S, Keech E, Kumar M, Lawton G, Nixon J, Wilkinson MS: Inhibitors of protein kinase C.2. substituted bisindolylmaleimides with improved potency and selectivity. J Med Chem 35:944, 1992
25. Wilkinson S, Parker P, Nixon J: Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochem J 294:335, 1993
26. Martiny-Baron G, Kazanietz M, Mischak H, Blumberg P, Kocks G, Hug H, Marmé D, Schächtele C: Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976. J Biol Chem 268:9194, 1993
27. Harris P, Ralph P: Human leukemic models of myelomonocytic development: A review of the HL-60 and U937 cell lines. J Leukoc Biol 37:407, 1985
28. Blumberg PM, Pettit GR: The bryostatins, a family of protein kinase C activators with therapeutic potential, in Krogsguard-Larsen P, Brogger Christensen S, Kofod H (eds): New Leads and Targets in Drug Research. Copenhagen, Denmark, Munksgaard, 1992, p 273
29. Kraft A, Reeves J, Ashendel C: Differing modulation of protein kinase C by bryostatin 1 and phorbol esters in JB6 mouse epidermal cells. J Biol Chem 263:8437, 1988
30. Dale I, Gescher A: Effects of activators of protein kinase C, including bryostatins 1 and 2, on the growth of A549. Int J Cancer 43:158, 1989
31. Szallasi Z, Smith C, Pettit GR, Blumberg P: Differential regulation of protein kinase C isozymes by bryostatin 1 and phorbol 12-myristate 13-acetate in NIH 3T3 fibroblasts. J Biol Chem 269:2118, 1994
32. Hennings H, Blumberg P, Pettit GR, Harald C, Shores R, Yuspa S: Bryostatin 1, an activator of protein kinase C, inhibits tumor promotion by phorbol esters in SENCAR mouse skin. Carcinogenesis 8:1343, 1987
33. Kraft A, Smith J, Berkow R: Bryostatin 1, an activator of the calcium phospholipid-dependent protein kinase blocks phorbol ester-induced differentiation of human promyelocytic leukemic cells HL-60. Proc Natl Acad Sci USA 83:1334, 1990
34. Dell'Aquila M, Nguyen H, Herald C, Pettit GR, Blumberg P: Inhibitin by bryostatin 1 of the phorbol ester-induced blockage of differentiation in hexamethylene bisacetamide-treated Friend erythroleukemia cells. Cancer Res 47:6006, 1987
35. Isakov N, Galron D, Mustelin T, Pettit GR, Altman A: Inhibition of phorbol ester-induced T cell proliferation is associated with rapid degradation of protein kinase C. J Immunol 150:1195, 1993